Methods Compared Classifying Intensity of Soil-Transmitted Helminth Infections
|
By LabMedica International staff writers Posted on 23 Jul 2020 |

Image: The FECPAKG2 is an internet connected, image based diagnostic platform scientifically validated to conduct fecal egg count (FEC) tests (Photo courtesy of Techion).
Soil-transmitted helminths (Ascaris lumbricoides, Trichuris trichiura) and the hookworms, Necator americanus and Ancylostoma duodenale affect one quarter of the world population, and are responsible for the loss of more than three million disability-adjusted life years (DALYs).
There are a variety of novel microscopy and DNA-based methods to identify soil-transmitted helminths, but it remains unclear whether applying current World Health Organization (WHO) thresholds on to these methods allows for a reliable classification of moderate-to-heavy intensity (M&HI) infections.
An international team of scientists led by those at Ghent University (Merelbeke, Belgium) defined method-specific thresholds and verified whether they increased the correct classification of M&HI infections in a multi-countries study. They evaluated both WHO and method-specific thresholds for classifying the M&HI infections for novel microscopic methods: McMaster egg counting technique, FECPAKG2 (Techion, Aberystwyth, UK), and Mini-FLOTAC (Federico II University of Naples, Naples, Italy) and DNA-based (qPCR) diagnostic methods (Elisabeth-Tweesteden Hospital, Tilburg, The Netherlands). The samples were also analyzed by Kato-Katz method as the reference method.
The team applied the WHO thresholds, the new microscopic methods mainly misclassified M&HI as low intensity, and to a lesser extent low intensity infection as M&HI. For FECPAKG2, applying the method-specific thresholds significantly improved the agreement for Ascaris (moderate → substantial), Trichuris and hookworms (fair → moderate). For Mini-FLOTAC, a significantly improved agreement was observed for hookworms only (fair → moderate). For the other STHs, the agreement was almost perfect and remained unchanged. For McMaster, the method-specific thresholds revealed a fair to a substantial agreement, but did not significantly improve the agreement. For qPCR, the method-specific thresholds based on genome equivalents per mL of DNA moderately agreed with the reference method for hookworms and Trichuris infections. For Ascaris, there was a substantial agreement.
The authors concluded that their results indicated that method-specific thresholds improved the classification of M&HI infections, but they stressed that validation studies are required before they can be recommended for general use in assessing M&HI infections in programmatic settings. The study also highlights the need (i) to agree on an absolute universal unit for qPCR, (ii) to align the evaluation of diagnostic methods with current STH program goals, and (iii) to define minimal and ideal (optimistic) criteria that diagnostic methods should meet in order to assess M&HI infections reliably. The study was published on July 2, 2020 in the journal PLOS Neglected Tropical Diseases.
Related Links:
Ghent University
Techion
Federico II University of Naples
Elisabeth-Tweesteden Hospital
There are a variety of novel microscopy and DNA-based methods to identify soil-transmitted helminths, but it remains unclear whether applying current World Health Organization (WHO) thresholds on to these methods allows for a reliable classification of moderate-to-heavy intensity (M&HI) infections.
An international team of scientists led by those at Ghent University (Merelbeke, Belgium) defined method-specific thresholds and verified whether they increased the correct classification of M&HI infections in a multi-countries study. They evaluated both WHO and method-specific thresholds for classifying the M&HI infections for novel microscopic methods: McMaster egg counting technique, FECPAKG2 (Techion, Aberystwyth, UK), and Mini-FLOTAC (Federico II University of Naples, Naples, Italy) and DNA-based (qPCR) diagnostic methods (Elisabeth-Tweesteden Hospital, Tilburg, The Netherlands). The samples were also analyzed by Kato-Katz method as the reference method.
The team applied the WHO thresholds, the new microscopic methods mainly misclassified M&HI as low intensity, and to a lesser extent low intensity infection as M&HI. For FECPAKG2, applying the method-specific thresholds significantly improved the agreement for Ascaris (moderate → substantial), Trichuris and hookworms (fair → moderate). For Mini-FLOTAC, a significantly improved agreement was observed for hookworms only (fair → moderate). For the other STHs, the agreement was almost perfect and remained unchanged. For McMaster, the method-specific thresholds revealed a fair to a substantial agreement, but did not significantly improve the agreement. For qPCR, the method-specific thresholds based on genome equivalents per mL of DNA moderately agreed with the reference method for hookworms and Trichuris infections. For Ascaris, there was a substantial agreement.
The authors concluded that their results indicated that method-specific thresholds improved the classification of M&HI infections, but they stressed that validation studies are required before they can be recommended for general use in assessing M&HI infections in programmatic settings. The study also highlights the need (i) to agree on an absolute universal unit for qPCR, (ii) to align the evaluation of diagnostic methods with current STH program goals, and (iii) to define minimal and ideal (optimistic) criteria that diagnostic methods should meet in order to assess M&HI infections reliably. The study was published on July 2, 2020 in the journal PLOS Neglected Tropical Diseases.
Related Links:
Ghent University
Techion
Federico II University of Naples
Elisabeth-Tweesteden Hospital
Latest Technology News
- Compact PCR Thermal Cycler Launches for Routine Molecular Laboratory Workflows
- New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows
- Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns
- Laser-Enhanced Assay Boosts Sensitivity for Colorectal Cancer Biomarker Detection
- New Automation Workflow Streamlines NGS Library Preparation for High-Volume Labs
- ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine
- Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions
- New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling
- Bacterial Vesicle Expression System Streamlines Production of Cancer Diagnostic Proteins
- Autonomous Robotic System Receives FDA Authorization for Blood Collection
- Interoperable Data Platform Standardizes Multi-Cancer Blood Test Results
- Training Device Improves Accuracy of Pooled Molecular Diagnostics
- New CE-Certified Software Advances Whole-Genome Cancer Testing
- National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
- AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
- Agentic AI Platform Supports Genomic Decision-Making in Oncology
Channels
Clinical Chemistry
view channel
Blood Proteins Linked to Mortality Risk and Biological Aging Across Organ Systems
Older adults of the same chronological age can differ markedly in health, chronic disease burden, and resilience. Biological age aims to capture these differences by reflecting how rapidly the body and... Read more
Two-Step Blood Test Improves Specificity for Alzheimer’s Diagnosis
Early Alzheimer’s disease can be difficult to identify before more severe cognitive symptoms emerge. Blood tests measuring phosphorylated tau protein p-tau217 may help detect disease-related changes, but... Read moreMolecular Diagnostics
view channel
Spinal Fluid Liquid Biopsy May Help Clarify Uncertain Brain Tumor Findings
Brain and spinal cord tumors can be difficult to diagnose when imaging is inconclusive or tissue biopsy cannot be performed safely. MRI changes may reflect cancer, inflammation, or treatment-related effects,... Read more
New NGS Panel Detects AML Fusions at MRD-Level Sensitivity
Genomic testing for acute myeloid leukemia (AML) can be limited by incomplete coverage of disease-associated alterations. Fusion events may remain undetected when workflows rely on multiple assays or lack... Read more
Updated Framework Guides Assessment of Actionable Cancer Biomarkers
Cancer care increasingly relies on molecular testing to guide targeted treatment selection. Broader use of tumor sequencing has expanded the volume and diversity of biomarker data available to oncologists,... Read more
Genomic Tissue Test Predicts Metastasis and Abiraterone Benefit in High-Risk Prostate Cancer
Prostate cancer is the most common cancer in men, affecting more than 1 million men worldwide in 2013. Its clinical course varies substantially between patients, complicating efforts to identify those... Read moreHematology
view channel
New Risk-Stratification Tool Predicts Relapse After Blinatumomab in Childhood ALL
Acute lymphoblastic leukemia in children and young people requires careful assessment of relapse risk, particularly as treatment approaches move beyond standard chemotherapy. Traditional relapse predictors... Read more
New Myelofibrosis Guidelines Recommend Expanded Genetic Testing at Diagnosis
Myelofibrosis is a rare, life-threatening blood cancer affecting up to six per 100,000 people. The disease causes scarring in the bone marrow, limiting the production of healthy blood cells and potentially... Read moreImmunology
view channel
Immune and Inflammatory Markers May Help Assess CAR T-Cell Complication Risk
Cytokine release syndrome (CRS) can occur after chimeric antigen receptor (CAR) T-cell therapy in patients with autoimmune disease. Identifying which patients are more likely to develop this complication... Read more
COVID-19 and Flu Combo Test Launches With FDA Clearance
Overlapping symptoms of COVID-19 and influenza can create diagnostic uncertainty, particularly in urgent and point-of-care settings. Rapid differentiation from a single specimen can streamline triage and... Read morePathology
view channel
Roche Launches Automated Test to Support Mesothelioma Differential Diagnosis
Mesothelioma is a rare, deadly cancer that forms in the tissue lining many internal organs. Most patients are diagnosed late, with median overall survival reported at 12 to 18 months. Differential diagnosis... Read more
Digital Pathology Test Stratifies Recurrence Risk in Early Breast Cancer
In hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer, accurate recurrence-risk assessment helps guide treatment decisions. However, individual risks... Read more
AI Pathology Tool Predicts DNA Repair Deficiency in High-Grade Serous Ovarian Cancer
High-grade serous tubo-ovarian carcinoma is an aggressive cancer arising in the ovaries or fallopian tubes. Some tumors exhibit homologous recombination deficiency (HRD), a feature reflecting impaired DNA repair.... Read moreTechnology
view channel
Compact PCR Thermal Cycler Launches for Routine Molecular Laboratory Workflows
Molecular laboratories rely on nucleic acid analysis to detect molecular information accurately and reproducibly across a wide range of applications. Supporting these routine workflows, a newly launched... Read more
New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows
Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read moreIndustry
view channel
Collaboration Brings Tumor-Informed MRD Monitoring to Breast Cancer Care in Abu Dhabi
For many patients, cancer treatment does not eliminate the risk of recurrence, which may occur months or years later and become harder to treat after spreading. Recurrence is often detected only after... Read more







